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peat analysis (MLVA) as described 
(1,3–5). Multilocus sequence typing 
proﬁ  les of these strains were identi-
cal to the type strain B. microti CCM 
4915T and strain CCM 4916. MLVA 
showed that these strains also clus-
tered with B.  microti strains CCM 
4915T and CCM 4916, with identical 
panel 1 and panel 2A genotypes but a 
different panel 2B genotype.
In summary, we successfully 
isolated B. microti from soil samples 
collected at the same site 7 years after 
primary isolation of this novel spe-
cies from common voles. B. microti 
could still be isolated from the same 
soil samples 6 months after storage at 
4°C. This ﬁ  nding indicates long-term 
survival of B. microti in soil; thus, soil 
might function as a reservoir of infec-
tion. Identiﬁ  cation of B. microti as a 
potential soil bacterium is consistent 
with Brucella spp. whole genome se-
quencing data, in particular with the 
genome sequence of B.  suis, which 
exhibits fundamental similarities with 
plant pathogens such as Agrobacterium 
spp. and Rhizobium spp. (6). Whether 
soil is the primary habitat of B. microti 
or other vectors, such as nematodes, 
remains to be investigated.
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Plasmodium 
falciparum in 
Ancient Egypt
To the Editor: Malaria is a dis-
ease caused by parasites of the genus 
Plasmodium. The infection is trans-
mitted to humans through the bites of 
female ﬂ  ies of the genus Anopheles. 
Four species of Plasmodium are patho-
genic to humans, and each leads to dif-
ferent clinical features: P. falciparum 
causes severe malaria with undulating 
high fever (malaria tropica); P. malar-
iae, P. vivax, and P. ovale cause less 
severe clinical courses of disease with 
the manifestations of malaria quartana 
(P. malariae) and malaria tertiana (P. 
vivax and P. ovale). Literary evidence 
for malaria infection dates back to the 
early Greek period when Hippocrates 
described the typical undulating fever 
(1), highly suggestive of plasmodial 
infection. Although it is believed that 
malaria widely affected early pre-Hip-
pocrates populations, until now only 1 
study, which used molecular analysis, 
clearly identiﬁ  ed P. falciparum in a 
Roman infant dating back to the 5th 
century AD (2). Two other studies used 
molecular analysis to identify more 
recent plasmodial DNA in ancient 
human remains, i.e., from 100–400 
years ago (3,4). A substantial number 
of nonspeciﬁ  c ampliﬁ  cations in these 
previous studies raised concerns as 
to the speciﬁ  city of current molecular 
markers for ancient malaria (3,4).
In this report, we describe the 
unambiguous identiﬁ   cation of an-
cient DNA (aDNA) for P. falciparum 
in ancient Egyptian mummy tissues 
from ≈4,000 years ago. We analyzed 
91 bone tissue samples from ancient 
Egyptian mummies and skeletons. 
The Egyptian material derived from 
the Predynastic to Early Dynastic site 
of Abydos (n = 7; 3500–2800 BC), a 
Middle Kingdom tomb in Thebes West 
(n = 42; 2050–1650 BC), and vari-
ous tomb complexes in Thebes West, 
which were built and used between 
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the Middle and New Kingdom until 
the Late Period (n = 42; c. 2050–500 
BC). All samples were ﬁ  rst tested for 
Plasmodium spp. DNA by using the 
heminested PCR for the 18S rDNA 
primer targets usually used for malaria 
identiﬁ  cation  (5). Direct sequencing 
was performed on those with posi-
tive ampliﬁ  cation products. Thereby, 
a high number of ampliﬁ  cation prod-
ucts of various sizes (including the ex-
pected size) were detected. However, 
on sequencing, all amplicons provided 
nonspeciﬁ   c products. Consequently, 
in a second set, all material was tested 
for the P. falciparum chloroquine-re-
sistance transporter gene (pfcrt gene) 
(6,7), which was also further charac-
terized by direct sequencing.
In this second set of experiments, 
2 of the 91 ancient Egyptian samples 
tested positive for the 134-bp frag-
ment of the pfcrt region of P. falci-
parum (Figure). The speciﬁ  city of the 
ampliﬁ  cation was veriﬁ  ed by sequenc-
ing, which showed 99% sequence 
concordance. The result was veriﬁ  ed 
by parallel analysis in 2 independent 
laboratories; observations were fully 
concordant. The 2 positive samples 
originated from 2 different tomb com-
plexes dating from the New Kingdom 
until Late Period (1500–500 BC). 
Each sample was obtained from adults 
who had osteopathologic evidence of 
chronic anemia. No positive results 
were found for the earlier samples 
from the Predynastic to Early Dynas-
tic or Middle Kingdom periods.
Previously, immunologic tests 
have been used to investigate the 
presence and incidence of malaria in 
ancient Egyptian mummies (8,9). Be-
cause >40% of all samples and 92% 
of samples from persons with bone 
lesions suggestive of chronic anemia 
tested positive for the P. falciparum 
histidine-rich protein-2 antigen, doubts 
as to the speciﬁ  city of those tests have 
been raised.
Our study unambiguously identi-
ﬁ  ed P. falciparum aDNA in Egyptian 
mummy samples, thereby proving a 
speciﬁ  c infection by falciparum ma-
laria in ancient Egypt. With respect to 
the infection incidence, our molecular 
analysis suggests a more realistic fre-
quency than had been previously sug-
gested by paleoimmunologic meth-
ods. Consequently, the aDNA analysis 
is superior with respect to the reaction 
speciﬁ  city, so that the latter should not 
further be used for that purpose.
This report adds another infec-
tious disease to the spectrum of paleo-
microbiology in ancient Egypt, thereby 
further explaining the previously pos-
tulated inﬂ  uence of infectious diseases 
on the low life expectancy for ancient 
Egyptian populations (10). Molecular 
detection of pathogen aDNA can be 
used not only to identify a certain dis-
ease, but it may also provide informa-
tion on disease frequency, evolution-
ary origin, and pathways.
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Figure. PCR ampliﬁ  cation of a 134-bp fragment of ancient DNA of Plasmodium falciparum 
in Egyptian mummies. Lane 1, molecular marker; lanes 10 and 11, 2 negative controls. 
One (lane 6) of 8 samples shows a positive ampliﬁ  cation product (arrow). Speciﬁ  city of the 
product was veriﬁ  ed by sequencing.
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Brucellosis in 
Infant after 
Familial Outbreak
To the Editor: Brucellosis is a 
known cause of small household out-
breaks (1,2), usually attributed to ex-
posure of all infected family members 
to the animal/animal product pathogen 
source. Although the means of disease 
transmission is well delineated (3), 
in certain cases the pathogen’s entry 
into the human body cannot be clearly 
deﬁ  ned; this has led to suggestions of 
direct human-to-human transmission 
and also to the increasing recogni-
tion of airborne brucellosis, which is 
important in the context of the role of 
Brucella spp. as potential biological 
weapons (4). Another understudied 
transmission route is entry by direct 
contact  through skin and mucosal 
abrasions. We report a case of in-
fantile brucellosis in which airborne 
transmission in the context of familial 
brucellosis or indirect contact with the 
animal source through other family 
members was considered the only pos-
sible means of infant infection. 
In 2006, a 2.5-month-old girl was 
admitted to the Pediatric Department 
of the University Hospital of Ioanni-
na, in a region of northwestern Greece 
where animal and human infection 
from Brucella melitensis is still com-
mon (5,6). She had a 2-week history 
of poor feeding and a 5-day history of 
swelling of the right wrist. She was 
born after 38 weeks’ gestation with 
a birthweight of 3,050 g and was fed 
formula milk exclusively. Results of 
the physical examination were normal 
except the ﬁ  nding of a tender swell-
ing of the right wrist. The infant came 
from a family of shepherds, and her 
father and paternal grandfather had 
been treated for brucellosis 10 and 22 
months ago, respectively. At that time, 
the whole family was screened for ad-
ditional cases; screening was also of-
ten repeated at the patients’ followup 
examinations. On admission, labora-
tory tests showed characteristic rela-
tive lymphocytosis (leukocytes 10.5 
× 109/L, 65.3% lymphocytes) and an 
increase in inﬂ  ammatory markers (C-
reactive protein, 22 mg/L, and eryth-
rocyte sedimentation rate, 47 mm/h). 
Results of a wrist x-ray were normal. 
Because brucellosis was suspected, 
serum agglutination test, ELISA, and 
blood PCR for B. melitensis were per-
formed. Agglutination titer was 640; 
ELISA immunoglobulin M (IgM) 
antibodies and PCR results were posi-
tive. No organisms were grown in 
blood culture.
All family members were re-
screened. The father and paternal 
grandfather had negative serum ag-
glutination and ELISA IgM and posi-
tive IgG serologic results, indicating 
past infection. The mother and pater-
nal grandmother were again negative. 
Veterinary investigation showed ac-
tive disease in a few sheep of the fam-
ily’s herd. The infant was treated with 
a combination of oral trimethoprim-
sulfamethoxazole and rifampin for 6 
weeks. The course of the illness was 
uneventful, and she recovered com-
pletely. Followup PCR results were 
negative for B. melitensis. Six months 
later, only an ELISA IgG had positive 
results; IgM and IgA antibody and ag-
glutination test results were negative. 
The patient remains without relapse 2 
years after treatment.
Awareness of brucellosis is low 
in disease-endemic areas, including 
knowledge of its transmission poten-
tial and its medical consequences.. 
As a consequence, familial clusters of 
brucellosis are the norm. Recognition 
of a human case should prompt inves-
tigation of other family members so 
that early recognition and treatment 
for other household case-patients 
are possible. However, limitations in 
eradicating the initial animal disease 
source may lead to continuous expo-
sure and appearance of new cases after 
a protracted period, or to infection of 
new household members.
Our case raises the need for 
awareness of the transmission dynam-
ics of Brucella spp. because the dis-
ease emerged in a household member 
who did not have any direct contact 
with the animal source or any related 
products. The baby was not breastfed 
and had not digested raw milk. Her 
feeding bottle was speciﬁ  cally  used 
for formulated milk and for feeding 
her only. Ingestion of breast milk from 
an infected mother (7) and vertical 
transmission transplacentally or dur-
ing delivery are acknowledged means 
of transmission (8), but in this case the 
mother had never had brucellosis (she 
had been repeatedly screened during 
her husband’s initial disease and fol-
lowup). Neither previously infected 
household member had any clinical 
or laboratory sign of relapse or re-
sidual disease. The infant was never in 
contact with the infected animals and 
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